-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SVPHIO4Sbt1CoiZ+RpQlV37DorUm78GdjaWFZUFZEyDT9gWwtqy4TwRBeEZNDGCs ZHiKP4O6MQTIEUfnNK1YJg== 0001019687-07-000707.txt : 20070314 0001019687-07-000707.hdr.sgml : 20070314 20070313214839 ACCESSION NUMBER: 0001019687-07-000707 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20070314 DATE AS OF CHANGE: 20070313 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ADVOCAT INC CENTRAL INDEX KEY: 0000919956 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 621559667 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43225 FILM NUMBER: 07692060 BUSINESS ADDRESS: STREET 1: 1621 GALLERIA BLVD. CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 6157717575 MAIL ADDRESS: STREET 1: 1621 GALLERIA BLVD. CITY: BRENTWOOD STATE: TN ZIP: 37027 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL INVESTMENT FUND LTD CENTRAL INDEX KEY: 0001174866 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: CALEDONIAN HOUSE STREET 2: JENNETT STREET, GEORGE TOWN CITY: GRAND CAYMAN STATE: E9 ZIP: # MAIL ADDRESS: STREET 1: CALEDONIAN HOUSE STREET 2: JENNETT STREET, GEORGE TOWN CITY: GRAND CAYMAN STATE: E9 ZIP: # FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL INVESTMENT FUND INC DATE OF NAME CHANGE: 20020605 SC 13D/A 1 bristol_13da3-advocate.txt AMENDMENT NO. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Advocat Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 007586100 - -------------------------------------------------------------------------------- (CUSIP Number) Amy Wang, Esq. Bristol Capital Advisors, LLC 10990 Wilshire Boulevard, Suite 1410, Los Angeles, CA 90024 (310) 696-0333 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 13, 2007 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 007586100 - -------------------------------------------------------------------------------- 1. Name of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Bristol Investment Fund, Ltd. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box If a Member of a Group (See Instructions) (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions) Cash - -------------------------------------------------------------------------------- 5. Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_] - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization Cayman Islands - -------------------------------------------------------------------------------- 7. Sole Voting Power NUMBER OF 256,861 SHARES ----------------------------------------------------------------- BENEFICIALLY 8. Shared Voting Power OWNED BY EACH ----------------------------------------------------------------- REPORTING 9. Sole Dispositive Power PERSON 256,861 WITH ----------------------------------------------------------------- 10. Shared Dispositive Power - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 256,861 - -------------------------------------------------------------------------------- 12. Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [_] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11) 4.4% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) CO - -------------------------------------------------------------------------------- The following constitutes Amendment No. 3 ("Amendment No. 3") to the Schedule 13D filed by the undersigned. This Amendment No. 3 amends the Schedule 13D as specifically set forth herein. Item 4 is hereby amended to include the following: ITEM 4. PURPOSE OF TRANSACTION On March 13, 2007, Bristol Investment Fund, Ltd. ("Bristol") sent a letter to the Chief Executive Officer of the Issuer. The letter is filed as Exhibit 1 hereto and is incorporated herein by reference. The letter addresses Bristol's concerns about the future role of the Chairman of the Board, the valuation of the Issuer's common stock, and the general direction of the Issuer. The letter also urges the Issuer to take certain measures to address Bristol's concerns and act in the best interests of all shareholders. Item 5(a) is hereby amended and restated as follows: ITEM 5. INTEREST IN SECURITIES OF THE ISSUER (a) As of the date of the filing of this Amendment No. 3 to Schedule 13D, Bristol owns 256,861 Shares, which represents approximately 4.4% of the Shares outstanding, based upon 5,836,287 Shares outstanding as of November 1, 2006 as reported in the Issuer's quarterly report on Form 10Q, as filed with the Securities and Exchange Commission on November 8, 2006. Bristol filed its initial Schedule 13D and amendments thereto voluntarily, although under no obligation to do so pursuant to the statute. As long as Bristol continues to hold less than 5% of the Shares outstanding, Bristol does not intend to file any further amendments to the Schedule 13D. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: March 13, 2007 BRISTOL INVESTMENT FUND, LTD. By: /s/ Paul Kessler EX-1 2 bristol_13da3-ex1.txt LETTER TO THE CEO OF THE ISSUER Exhibit 1 March 13, 2007 VIA FACSIMILE AND ELECTRONIC MAIL - --------------------------------- Mr. William R. Council, III President and Chief Executive Officer Advocat Inc. 1621 Galleria Boulevard Brentwood, Tennessee 37027 Fax: (615) 771-7409 E-mail: wcouncil@advocat-inc.com ------------------------ Dear Mr. Council: I enjoyed speaking with you and Glynn Riddle today regarding Advocat Inc. (the "Company"). As one of the Company's largest shareholders, Bristol Investment Fund, Ltd. ("Bristol") feels it is imperative that management align its interests with that of its shareholders. It is disappointing to hear that the Company's Chairman of the Board, Wallace Olsen, will no longer be a spokesperson for the Company. We are concerned about the public perception of this change, as it is customary for chairpersons of public companies to champion their cause with management, employees, shareholders, and the investment community. Will Mr. Olsen's role going forward change in other ways? Will Mr. Olsen retain the chairmanship? Is a succession plan in place? Furthermore, we believe that the Company is currently undervalued based on a variety of industry metrics. I strongly urge you to have Mr. Olsen contact me to discuss these concerns. In accordance with our discussion, we recommend that the Company take the following actions: a) Establish a special committee of directors which would immediately retain a well-known industry financial advisor to start an auction process and solicit offers for the Company and or engage in discussions with strategic buyers. b) Appoint a committee of outside directors to evaluate all potential offers and other financial alternatives. c) Refrain from expansion opportunities and focus resources on a stock buyback plan, especially at current prices. d) Work to nominate two Board members of Bristol's choice, which we agreed would be something you would inquire about with the Company's attorneys and report back to us. As one of the Company's larger shareholders, we would prefer to work with you and the Board in a cooperative manner and hope that you appreciate that working with us is strongly in the Company's best interest and that of all shareholders. I suggest we schedule a time in the near future to personally meet and further discuss strategic initiatives. We remain optimistic about the Company's prospects and trust that you will diligently work to address our concerns. Yours truly, /s/ Paul Kessler ---------------- Paul Kessler Manager, Bristol Capital Advisors, LLC -----END PRIVACY-ENHANCED MESSAGE-----